PERSPECTIVE THERAPEUTICS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $12.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-10
- PERSPECTIVE THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was $2.26M, a 113.52% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $10.15M.
- PERSPECTIVE THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was $1.06M.
- PERSPECTIVE THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-03-31 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month |
|---|---|---|---|
| 2026-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $12.41M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $10.15M 10-Q · filed 2026-05-11 | ||
| 2025-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.06M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | ||
| 2024-09-30 | $16.52M 10-Q · filed 2024-11-12 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |